The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity

被引:72
作者
Mishra, S [1 ]
Murphy, LJ [1 ]
机构
[1] Univ Manitoba, Dept Physiol & Internal Med, Winnipeg, MB R3E 0W3, Canada
基金
加拿大健康研究院;
关键词
transglutaminase; p53; Mdm2; apoptosis; serine/threonine kinase;
D O I
10.1016/j.bbrc.2005.11.071
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increased expression and activity of the ubiquitous enzyme, tissue transglutaminase (TG2), is consistently seen in a variety of models of apoptosis. The p53 oncoprotein is also involved in apoptosis. Here we investigated the interaction of TG2 with p53 and show that the p53 is a substrate for the recently identified serine/threonine kinase activity of TG2. Phosphospecific antibodies indicated that TG2 phosphorylated p53 at Set 15 and Ser 20, residues that are critically important in the interaction of p53 with Mdm2. The TG2-induced phosphorylation was abrogated by high Ca2+ concentrations and inhibited by cystamine, a known inhibitor of TG2 cross-linking activity. Furthermore, we demonstrate that TG2-induced phosphorylation of p53 reduces the ability of p53 to interact with Mdm2. Although TG2 cross-linking activity has been clearly implicated in apoptosis, our observations reported here suggest TG2 modification of p53 could be an additional mechanism whereby TG2 could facilitate apoptosis. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:726 / 730
页数:5
相关论文
共 32 条
[1]  
Akimov SS, 2001, J CELL SCI, V114, P2989
[2]   p53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1 [J].
Asher, G ;
Lotem, J ;
Tsvetkov, P ;
Reiss, V ;
Sachs, L ;
Shaul, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (25) :15065-15070
[3]   A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway [J].
Brignone, C ;
Bradley, KE ;
Kisselev, AF ;
Grossman, SR .
ONCOGENE, 2004, 23 (23) :4121-4129
[4]   Glutamate-induced increases in transglutaminase activity in primary cultures of astroglial cells [J].
Campisi, A ;
Caccamo, D ;
Raciti, G ;
Cannavò, G ;
Macaione, V ;
Currò, M ;
Macaione, S ;
Vanella, A ;
Ientile, R .
BRAIN RESEARCH, 2003, 978 (1-2) :24-30
[5]   alpha(1)-adrenergic receptor signaling via G(h) is subtype specific and independent of its transglutaminase activity [J].
Chen, SH ;
Lin, F ;
Iismaa, S ;
Lee, KN ;
Birckbichler, PJ ;
Graham, RM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (50) :32385-32391
[6]  
Cummings M, 1996, J PATHOL, V179, P288, DOI 10.1002/(SICI)1096-9896(199607)179:3<288::AID-PATH574>3.0.CO
[7]  
2-M
[8]   PHOSPHORYLATION OF DARPP-32, A DOPAMINE-REGULATED AND CAMP-REGULATED PHOSPHOPROTEIN, BY CASEIN KINASE-I IN-VITRO AND IN-VIVO [J].
DESDOUITS, F ;
COHEN, D ;
NAIRN, AC ;
GREENGARD, P ;
GIRAULT, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (15) :8772-8778
[9]   Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover [J].
Dumaz, N ;
Milne, DM ;
Jardine, LJ ;
Meek, DW .
BIOCHEMICAL JOURNAL, 2001, 359 :459-464
[10]   Transglutaminase 2: an enigmatic enzyme with diverse functions [J].
Fesus, L ;
Piacentini, M .
TRENDS IN BIOCHEMICAL SCIENCES, 2002, 27 (10) :534-539